Skip to Main Content

Pharmacy benefit managers are finding themselves in the spotlight more than they used to — and their top lobbyist doesn’t mind.

PBMs and the lobbyists who advocate for them, unsurprisingly, see things differently from Congressman Doug Collins of Georgia, a Republican who last week excoriated PBMs in an interview with STAT. STAT also spoke with Mark Merritt, the CEO of the Pharmaceutical Care Management Organization, about how PBMs view their work.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

  • What a bunch of crap this guy is throwing at you ! There is only one type of transparency ! and the PBM’s don’t want anybody to see what they’re doing.
    Ask the PBM’s to show their clients how much they reimburse pharmacies.
    Who keeps the hundred’s of millions of dollars they’re stealing in D.I.R fees?
    Why do they still base their drug cost on a ficticous number (AWP) ?
    It’s all smoke and mirrors so they can continue to rob from all of us.
    Why are PBM’s still reimbursing pharmacies $50-$75 below their cost on prescriptions?

Comments are closed.